Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;3(9):559-72.
doi: 10.1002/emmm.201100159. Epub 2011 Aug 3.

Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment

Jacques Amar  1 , Chantal Chabo, Aurélie Waget, Pascale Klopp, Christelle Vachoux, Luis G Bermúdez-Humarán, Natalia Smirnova, Mathieu Bergé, Thierry Sulpice, Sampo Lahtinen, Arthur Ouwehand, Philippe Langella, Nina Rautonen, Philippe J Sansonetti, Rémy Burcelin
Affiliations

Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment

Jacques Amar et al. EMBO Mol Med. 2011 Sep.

Abstract

A fat-enriched diet modifies intestinal microbiota and initiates a low-grade inflammation, insulin resistance and type-2 diabetes. Here, we demonstrate that before the onset of diabetes, after only one week of a high-fat diet (HFD), live commensal intestinal bacteria are present in large numbers in the adipose tissue and the blood where they can induce inflammation. This translocation is prevented in mice lacking the microbial pattern recognition receptors Nod1 or CD14, but overtly increased in Myd88 knockout and ob/ob mouse. This 'metabolic bacteremia' is characterized by an increased co-localization with dendritic cells from the intestinal lamina propria and by an augmented intestinal mucosal adherence of non-pathogenic Escherichia coli. The bacterial translocation process from intestine towards tissue can be reversed by six weeks of treatment with the probiotic strain Bifidobacterium animalis subsp. lactis 420, which improves the animals' overall inflammatory and metabolic status. Altogether, these data demonstrate that the early onset of HFD-induced hyperglycemia is characterized by an increased bacterial translocation from intestine towards tissues, fuelling a continuous metabolic bacteremia, which could represent new therapeutic targets.

PubMed Disclaimer

Figures

Figure 1
Figure 1. High-fat diet increases the concentration of bacterial DNA in blood, mesenteric adipose tissue (MAT), and corresponding lymph nodes (MLN) before the onset of diabetes. The pathogen recognition receptors Nod1 and CD14, but not Nod2, control high-fat diet-induced bacterial DNA accumulation in tissues. The regulatory role of leptin
16S rRNA DNA concentration (pg/µg total DNA; qPCR):

  1. A,B,C. From total bacteria in blood (A), MAT (B) and MLN (C) of normal chow (NC)-fed, prediabetic (HFD 1 week), and diabetic mice (HFD 4 weeks) (mean ± SEM; n = 8).

  2. D,E. From total bacteria in blood (D), and MAT (E) of Nod1-deficient mice (Nod1−/−), and Nod2-deficient mice (Nod2−/−), after 4 weeks of a normal chow (NC) or a high-fat diet (HFD 4 weeks) (mean ± SEM; n = 11).

  3. F,G. From total bacteria in blood (F), and MAT (G), of ob/ob, ob/obxCD14−/−, and CD14−/− mice (all NC-fed) (mean ± SEM; n = 8).

    Data with identical superscript letters (A–G) do not differ from each other with p > 0.05.

Figure 2
Figure 2. The pathogen recognition receptors Nod1 and CD14, but not Nod2, control high-fat diet-induced glucose intolerance, diabetes and fat mass gain. The regulatory role of leptin

  1. A,B,C. Oral glucose tolerance test (OGTT) (1.5 g/kg) in Nod1-deficient mice (Nod1−/−) (A), Nod2-deficient mice (Nod2−/−) (B) and their corresponding wild-type controls (WT) after 4 weeks of a normal chow (NC) or a high-fat diet (HFD) and corresponding index (µM/min) from 15 to 120 min after glucose administration (C) (mean ± SEM; n = 11; *p < 0.05; data with identical superscript letters do not differ from each other with p > 0.05).

  2. D,E,F. Fat mass (% of body weight; EchoMRI) (D), fasted plasma insulin (µU/ml) (E) and insulin sensitivity (glucose turnover rate in mg/kg min) (F), in Nod1−/− or Nod2−/− mice and their corresponding WT controls after 4 weeks of a NC or a HFD (mean ± SEM; n = 11 (D); 8 (E); or 5 (F); data with identical superscript letters do not differ from each other with p > 0.05).

  3. G. Intraperitoneal glucose tolerance test (IPGTT) (1 g/kg) in WT, ob/ob, ob/obxCD14−/− and CD14−/− mice (all NC-fed) (mean ± SEM; n = 8; *p < 0.05 versus ob/ob).

  4. H. IPGTT corresponding index (µM/min) from 30 min before to 90 min after glucose administration (mean ± SEM; n = 8; data with identical superscript letters do not differ from each other with p > 0.05).

  5. I. Fat mass (% of body weight; EchoMRI) in WT, ob/ob, ob/obxCD14−/− and CD14−/− mice (all NC-fed) (mean ± SEM; n = 8; data with identical superscript letters do not differ from each other with p > 0.05).

Figure 3
Figure 3. Metabolic disturbances and increased bacterial translocation to mesenteric adipose tissue (MAT) in Myd88 knockout mice

  1. A. Intraperitoneal glucose tolerance test (IPGTT) (1 g/kg) in Myd88-deficient mice (Myd88−/−) and their corresponding wild-type controls (WT) fed a normal chow (NC) diet (mean ± SEM; n = 7; *p < 0.05 versus controls).

  2. B,C,D,E. Body weight (B), fat mass (% of body weight; EchoMRI) (C), fasted plasma insulin (µU/ml) (D) and insulin sensitivity (glucose turnover rate in mg/kg min) (E), in Myd88−/− mice and their corresponding WT controls fed a NC diet (mean ± SEM; n = 5; data with identical superscript letters do not differ from each other with p > 0.05).

  3. F. Number of GFP-E. coli cfu per g of MAT in Myd88−/− mice and their corresponding WT controls fed a NC diet, 2 h post-gavage with 109 cfu of GFP-E. coli (mean ± SEM; n = 7; data with identical superscript letters do not differ from each other with p > 0.05).

  4. G. 16S rRNA DNA concentration (pg/µg total DNA; qPCR) from total bacteria in MAT of Myd88−/− mice and their corresponding WT controls fed a NC diet (mean ± SEM; n = 7; data with identical superscript letters do not differ from each other with p > 0.05).

Figure 4
Figure 4. Intestinal mucosal adherence and transmucosal passage of bacteria are increased during high-fat diet (HFD) treatment before the onset of diabetes, and intestinal bacteria co-localize with dendritic cells of lamina propria and mesenteric lymph nodes (MLN)

  1. A. Bacterial adherence (GFP-E. coli cfu per cm of mucosa/GFP-E. coli cfu per cm of lumen) in normal chow (NC)-fed (Control NC), prediabetic (HFD 1 week), and diabetic mice (HFD 4 weeks), 2 h after gavage with 109 cfu of GFP-E. coli (Duo, duodenum; Jej, jejunum; Ile, ileum; Cæ, cæcum) (mean ± SEM; n = 10–12; data with identical superscript letters do not differ from each other with p > 0.05).

  2. B. Fluorescence microscopy of scrapped ileal mucosa from NC-fed (Control NC) and prediabetic mice (HFD 1 week), 2 h after gavage with 109 cfu of GFP-E. coli. Bars = 20 µm.

  3. C. Corresponding number of GFP-E. coli/mm2 of scrapped ileal mucosa (fluorescence microscopy) (mean ± SEM; n = 6; data with identical superscript letters do not differ from each other with p > 0.05).

  4. D. Fluorescence microscopy of DAPI-counterstained cryosections of ileum from NC-fed (Control NC) and prediabetic mice (HFD 1 week), 2 h after gavage with 109 cfu of GFP-E. coli. Right panel corresponds to magnification of surrounded region. Bars = 20 µm.

  5. E. Corresponding number of transmucosal GFP-E. coli/mm2 of ileum section (fluorescence microscopy) (mean ± SEM; n = 6; data with identical superscript letters do not differ from each other with p > 0.05).

  6. F,H. Immunofluorescent labelling of CD11c-positive cells [dendritic cells (DC) in red] and co-localization with fluorescent GFP-E. coli (green) on DAPI-counterstained (nuclei in blue) cryosections of ileum (F), and MLN (H), from NC-fed (Control NC), and diabetic mice (HFD 4 weeks), 2 h after gavage with 109 cfu of GFP-E. coli. Arrows point co-localizations (yellow). Right panels correspond to magnification of surrounded regions. Bars = 20 µm.

  7. G,I. Corresponding quantification of CD11c-positive cells co-localized with GFP-E. coli (% of total DC) in ileum (G) and MLN (I) (mean ± SEM; n = 6; data with identical superscript letters do not differ from each other with p > 0.05).

Figure 5
Figure 5. TNF-α expression in mesenteric adipose tissue (MAT) correlates positively with bacterial DNA concentration in ileum before the onset of high-fat diet-induced diabetes

  1. A. 16S rRNA DNA concentration (ng/µg total DNA; qPCR) from total bacteria in mucosa and lumen of ileum, in normal chow (NC)-fed, prediabetic (HFD 1 week), and diabetic mice (HFD 4 weeks) (mean ± SEM; n = 6; data with identical superscript letters do not differ from each other with p >0.05).

  2. B. Concentration of mRNA coding for the inflammatory markers TNF-α, IL-1β, PAI-1, IL-6 and IFN-γ in MAT of normal chow (NC)-fed, prediabetic and diabetic mice (RT-qPCR) (mean ± SEM; n = 6; data with identical superscript letters do not differ with p > 0.05; expressions of the different markers were not compared between themselves).

  3. C,D. Correlations between TNF-α expression in MAT and bacterial concentration (ng 16S rRNA DNA/µg total DNA; qPCR), of ileal lumen (C), and ileal mucosa (D), in NC-fed, prediabetic (HFD 1 week), and diabetic mice (HFD 4 weeks).

Figure 6
Figure 6. Probiotic-mediated intestinal leptin delivery reverses high-fat diet (HFD)-metabolic disturbances, bacterial adherence and translocation, and mesenteric adipose tissue (MAT) inflammation
HFD-fed WT mice were orally treated with 109 cfu/day of leptin-producing Lactococcus lactis (L. lactis leptin) and their corresponding controls orally treated with 109 cfu/day of Lactococcus lactis (L. lactis).

  1. A,B. Body weight gain (% of initial weight) (A), fat mass change during treatment in % of body weight (EchoMRI) (B) (mean ± SEM; n = 6; *p < 0.05 versus controls (A); data with identical superscript letters do not differ from each other with p > 0.05 (B)).

  2. C,D. Oral glucose tolerance test (OGTT) (1.5 g/kg) (C), and corresponding index (µM/min) from 30 min before to 120 min after glucose administration (D) (mean ± SEM; n = 6; *p < 0.05 versus controls (C); data with identical superscript letters do not differ from each other with p > 0.05 (D)).

  3. E,F,G,H. Fed plasma insulin (µU/ml) (E), GFP-E. coli adherence (GFP-E. coli cfu per cm of mucosa/GFP-E. coli cfu per cm of lumen) in ileum and cæcum, 2 h post-gavage with 109 cfu of GFP-E. coli (F), number of GFP-E. coli cfu per g of MAT, 2 h post-gavage with 109 cfu of GFP-E. coli (G), and 16S rRNA DNA concentration (pg/µg total DNA; qPCR) from total bacteria in MAT (H) (mean ± SEM; n = 6; data with identical superscript letters do not differ from each other with p > 0.05).

  4. I. Concentration of mRNA coding for the inflammatory markers TNF-α, IL-1β, PAI-1, IL-6 and IFN-γ in MAT (RT-qPCR) (mean ± SEM; n = 6; data with identical superscript letters do not differ with p > 0.05; expressions of the different markers were not compared between themselves).

Figure 7
Figure 7. Probiotic-mediated intestinal leptin delivery reverses metabolic disturbances, bacterial adherence and translocation, and mesenteric adipose tissue (MAT) inflammation in ob/ob mice
ob/ob mice were orally treated with 109 cfu/day of leptin-producing Lactococcus lactis (L. lactis leptin) and their corresponding controls orally treated with 109 cfu/day of Lactococcus lactis (L. lactis).

  1. A,B. Body weight gain (% of initial weight) (A), fat mass change during treatment time course (% of body weight; EchoMRI) (B) (mean ± SEM; n = 6; *p < 0.05 versus controls (A); data with identical superscript letters do not differ from each other with p > 0.05 (B)).

  2. C,D. Intraperitoneal glucose tolerance test (IPGTT) (1 g/kg) (C), and corresponding index (µM/min) from 30 min before to 90 min after glucose administration (D) (mean ± SEM; n = 6; *p < 0.05 versus controls (C); data with identical superscript letters do not differ from each other with p > 0.05 (D)).

  3. E,F,G,H,I. Fed plasma insulin (µU/ml) (E), GFP-E. coli adherence (GFP-E. coli cfu per cm of mucosa/GFP-E. coli cfu per cm of lumen) in ileum and cæcum, 2 h post-gavage with 109 cfu of GFP-E. coli (F), number of GFP-E. coli cfu per g of MAT, 2 h post-gavage with 109 cfu of GFP-E. coli (G), 16S rRNA DNA concentration (pg/µg total DNA; qPCR) from total bacteria in MAT (H), 16S rRNA concentration (pg/µg total RNA; RT-qPCR) from total bacteria in MAT (I) (mean ± SEM; n = 6; data with identical superscript letters do not differ from each other with p > 0.05).

  4. J. Concentration of mRNA coding for the inflammatory markers TNF-α, IL-1β, PAI-1, IL-6 and IFN-γ in MAT (RT-qPCR, 2−ΔΔCt) (mean ± SEM; n = 6; data with identical superscript letters do not differ with p > 0.05; expressions of the different markers were not compared between themselves).

Figure 8
Figure 8. A probiotic treatment with Bifidobacterium lactis 420 reverses high-fat diet (HFD)-induced bacterial adherence and translocation, adipose tissue (MAT) inflammation and insulin resistance

  1. A,B. Luminal (A) and mucosal (B) number of colony forming units (cfu) per cm of duodenum (Duo), jejunum (Jej), ileum (Ile), and cæcum (Cæ), 2 h following oral gavage with 109 cfu of GFP-E. coli.) (mean ± SEM; n = 8; data with identical superscript letters do not differ with p > 0.05).

  2. C. Difference in major groups of bacteria in MAT (qPCR), between HFD and NC groups (left panel), and HFD + B420 and HFD groups (right panel) (mean ± SEM; n = 8; *p < 0.05).

  3. D. Concentration of mRNA coding for the inflammatory markers TNF-α, IL-1β, PAI-1 and IL-6 in MAT (RT-qPCR) (mean ± SEM; n = 8–10; data with identical superscript letters do not differ with p > 0.05; expressions of the different markers were not compared between themselves).

  4. E. Insulin sensitivity (glucose turnover rate in mg/kg min). (mean ± SEM; n = 8–10; data with identical superscript letters do not differ with p > 0.05).

See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Amar J, Burcelin R, Ruidavets J, Cani P, Fauvel J, Alessi M, Chamontin B, Ferrieres J. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr. 2008;87:1219–1223. - PubMed
    1. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004;101:15718–15723. - PMC - PubMed
    1. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science. 2005;307:1915–1920. - PubMed
    1. Bermudez-Humaran LG, Nouaille S, Zilberfarb V, Corthier G, Gruss A, Langella P, Issad T. Effects of intranasal administration of a leptin-secreting Lactococcus lactis recombinant on food intake, body weight, and immune response of mice. Appl Environ Microbiol. 2007;73:5300–5307. - PMC - PubMed
    1. Burcelin R, Crivelli V, Dacosta A, Roy-Tirelli A, Thorens B. Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. Am J Physiol Endocrinol Metab. 2002;282:E834–E842. - PubMed

MeSH terms

Substances